At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 41 enrolled
Drug / intervention
A-101 Topical Solutiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Study Assessing Subject Satisfaction With A-101 Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment for Seborrheic Keratoses of the Face, Neck, and Decolletage
In Brief
A Phase 4 clinical trial evaluating A-101 Topical Solution for Seborrheic Keratosis. Completed, enrolled 41 participants across 3 sites.
Detailed Summary
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeborrheic Keratosis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartMar 2018
First PostedApr 2018
Primary CompletionNov 2018
TodayJul 2026
First PostedApr 4, 2018
Enrollment StartMar 21, 2018
Primary CompletionNov 14, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.2 years ago
Interventions
A-101 Topical Solutiondrug
A-101 Topical Solution applied Day 1, Day 15 and Day 29